Women with BOL (n = 40) | Women with HGSOC (n = 31) | Total | P-value (unpaired) | P-value (paired) | |
---|---|---|---|---|---|
AGE (years) | |||||
Mean (SD) | 63.7 (9.4) | 64.8 (9.6) | 64.2 (9.5) | ||
Median [IQR] | 64.7 [57.7; 70.9] | 64.8 [58.3; 70.7] | 64.8 [58.0; 71.0] | 0.65 a | 0.13 d |
POST-MENOPAUSAL STATUS | |||||
Yes (%) | 33 (80.4) | 21 (91.3) | 54 (76.1) | ||
No (%) | 4 (9.8) | 2 (6.7) | 6 (8.4) | 0.29 b | |
Missing (%) | 4 (9.8) | 7 (23.3) | 11 (15.5) | ||
TUMOR STAGE | |||||
I | – | 3 | 3 | ||
II | – | 3 | 3 | ||
III | – | 21 | 21 | ||
IV | – | 4 | 4 | ||
TUMOR MARKERS | |||||
CA125 (U/mL) | |||||
Mean (SD) | 21 (12) | 422 (1358) | 196 (913) | ||
Median [IQR] | 17 [12; 27] | 54 [29; 301] | 27 [14; 53] | 1.4 E-7 c**** | 5.3 E-6 e**** |
HE4 (pmol/L) | |||||
Mean (SD) | 66 (25) | 539 (1185) | 244 (754) | ||
Median [IQR] | 57 [49, 83] | 155 [93; 447] | 77 [54; 129] | 2.2 E-7 c**** | 2.0 E-5 e**** |
Missing | 2 (5.0%) | 8 (25.8%) | 10 (14.1%) | ||
LIPIDS | |||||
TG (mmol/L) | |||||
Mean (SD) | 1.45 (0.71) | 1.46 (0.65) | 1.45 (0.68) | ||
Median [IQR] | 1.23 [0.95; 1.74] | 1.34 [1.02; 1.63] | 1.34 [0.99; 1.70] | 0.87 c | 0.92 d |
Lp(a) (nmol/L) | |||||
Mean (SD) | 73.9 (88.0) | 74.4 (98.0) | 74.1 (91.8) | ||
Median [IQR] | 34.5 [12; 106] | 21.0 [7; 134] | 28.0 [11; 111] | 0.66 c | 0.63 d |
HDL (mmol/L) | |||||
Mean (SD) | 1.55 (0.46) | 1.45 (0.33) | 1.51 (0.41) | ||
Median [IQR] | 1.48 [1.22; 1.76] | 1.49 [1.15; 1.68] | 1.49 [1.19; 1.73] | 0.26 a | 0.24 d |
TC (mmol/L) | |||||
Mean (SD) | 5.35 (1.09) | 5.39 (1.05) | 5.37 (1.07) | ||
Median [IQR] | 5.42 [4.41; 6.15] | 5.16 [4.44; 6.26] | 5.28 [4.43; 6.24] | 0.93 c | 0.96 d |
Apo B (g/L) | |||||
Mean (SD) | 1.00 (0.23) | 1.03 (0.26) | 1.01 (0.24) | ||
Median [IQR] | 0.99 [0.81; 1.16] | 0.99 [0.85; 1.17] | 0.99 [0.83; 1.16] | 0.63 a | 0.82 d |
Non-HDL (mmol/L) | |||||
Mean (SD) | 3.79 (1.00) | 3.94 (1.02) | 3.86 (1.01) | ||
Median [IQR] | 3.73 [2.91; 4.56] | 3.77 [3.08; 4.76] | 3.77 [3.01; 4.70] | 0.55 a | 0.72 d |
LDL (mmol/L) | |||||
Mean (SD) | 3.13 (0.98) | 3.28 (0.97) | 3.20 (0.98) | ||
Median [IQR] | 3.08 [2.38; 3.80] | 3.17 [2.39; 3.98] | 3.10 [2.38; 3.84] | 0.54 a | 0.69 d |
LIPID-RELATED FACTORS | |||||
Apo CIII (μg/mL) | |||||
Mean (SD) | 526 (241) | 615 (306) | 569 (276) | ||
Median [IQR] | 485 [404; 616] | 562 [459; 826] | 508 [404; 688] | 0.15 c | 0.33 d |
Missing | 8 (20.0%) | 1 (3.2%) | 9 (12.7%) | ||
ANGPTL3 (ng/mL) | |||||
Mean (SD) | 67 (31) | 84 (29) | 74 (31) | ||
Median [IQR] | 65 [46; 86] | 77 [66; 102] | 70 [51; 92] | 0.019 a * | 0.030 d * |
PCSK9 (ng/mL) | |||||
Mean (SD) | 108 (32) | 103 (38) | 106 (35) | ||
Median [IQR] | 104 [87; 118] | 97 [79; 113] | 103 [82; 117] | 0.33 c | 0.44 d |